United Therapeutics (UTHR)
(Real Time Quote from BATS)
$347.68 USD
+2.05 (0.59%)
Updated Sep 9, 2024 03:33 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Price, Consensus and EPS Surprise
UTHR 347.68 +2.05(0.59%)
Will UTHR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for UTHR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for UTHR
United Therapeutics (UTHR) Up 9.9% Since Last Earnings Report: Can It Continue?
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
UTHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merck Stock Worth Watching on PAH Drug Winrevair's Approval in Europe?
Liquidia (LQDA) Down on FDA Delaying Full Approval for Yutrepia
Is First Trust Mid Cap Value AlphaDEX ETF (FNK) a Strong ETF Right Now?
Other News for UTHR
United Therapeutics Larger Than S&P 500 Component Kimco Realty
Keros gains after trial update on lung disorder therapy
FNDA: Lagging Other Factor-Based Small-Cap ETFs
Liquidia requests preliminary injunction against FDA for Tyvaso 3-year exclusivity
Ambarella To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Wednesday